PMVP logo

PMV Pharmaceuticals (PMVP)

Profile

Full Name

PMV Pharmaceuticals, Inc.

Ticker Symbol

PMVP

Exchange

NASDAQ

Country

United States

IPO

September 25, 2020

Indexes

Not included

Employees

47

Key Details

Price

$1.00(-3.85%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.14(+20.83% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 HC Wainwright & Co.
Buy
Aug 20, 24 HC Wainwright & Co.
Buy
May 30, 24 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
May 13, 24 Craig-Hallum
Buy
Apr 12, 24 Jefferies
Buy
Mar 7, 24 HC Wainwright & Co.
Buy
Dec 27, 23 Ladenburg Thalmann
Buy
Oct 16, 23 HC Wainwright & Co.
Buy
Aug 11, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for PMV Pharmaceuticals?
  • Does PMV Pharmaceuticals pay dividends?
  • What sector is PMV Pharmaceuticals in?
  • What industry is PMV Pharmaceuticals in?
  • What country is PMV Pharmaceuticals based in?
  • When did PMV Pharmaceuticals go public?
  • Is PMV Pharmaceuticals in the S&P 500?
  • Is PMV Pharmaceuticals in the NASDAQ 100?
  • Is PMV Pharmaceuticals in the Dow Jones?
  • When was PMV Pharmaceuticals's last earnings report?
  • When does PMV Pharmaceuticals report earnings?
  • Should I buy PMV Pharmaceuticals stock now?

What is the ticker symbol for PMV Pharmaceuticals?

The ticker symbol for PMV Pharmaceuticals is NASDAQ:PMVP

Does PMV Pharmaceuticals pay dividends?

No, PMV Pharmaceuticals does not pay dividends

What sector is PMV Pharmaceuticals in?

PMV Pharmaceuticals is in the Healthcare sector

What industry is PMV Pharmaceuticals in?

PMV Pharmaceuticals is in the Biotechnology industry

What country is PMV Pharmaceuticals based in?

PMV Pharmaceuticals is headquartered in United States

When did PMV Pharmaceuticals go public?

PMV Pharmaceuticals's initial public offering (IPO) was on September 25, 2020

Is PMV Pharmaceuticals in the S&P 500?

No, PMV Pharmaceuticals is not included in the S&P 500 index

Is PMV Pharmaceuticals in the NASDAQ 100?

No, PMV Pharmaceuticals is not included in the NASDAQ 100 index

Is PMV Pharmaceuticals in the Dow Jones?

No, PMV Pharmaceuticals is not included in the Dow Jones index

When was PMV Pharmaceuticals's last earnings report?

PMV Pharmaceuticals's most recent earnings report was on Mar 3, 2025

When does PMV Pharmaceuticals report earnings?

The next expected earnings date for PMV Pharmaceuticals is May 9, 2025

Should I buy PMV Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page